LaRowe Lisa R, Bakhshaie Jafar, Greenberg Jonathan
Division of Palliative Care and Geriatric Medicine, Mongan Institute Center for Aging and Serious Illness, Massachusetts General Hospital, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.
J Clin Psychol Med Settings. 2024 Dec 25. doi: 10.1007/s10880-024-10062-0.
Chronic orofacial pain (COFP; i.e., musculoskeletal, neurovascular, or neuropathic pain in the face, mouth, or jaw that lasts for at least 3 months) is prevalent and debilitating. Chronic pain and substance use frequently co-occur, and individuals with COFP face unique challenges (e.g., uncertainty about future pain episodes, difficulty eating, drinking and talking) that may influence substance use. Nevertheless, no work to date has comprehensively assessed substance use among individuals with COFP. Here, we examine the prevalence of substance use among adults with COFP. Participants included 246 adults with COFP who were recruited from the Facial Pain Association. Participants completed an online survey that included a comprehensive assessment of substance use (i.e., Alcohol, Smoking, and Substance Involvement Screening Test) between December 2023 and January 2024. Most participants (82.9%) have used ≥ 1 substance in their lifetime, over two-thirds (68.3%) currently use ≥ 1 substance, and nearly half (43.5%) engage in risky substance use. The most commonly used substances were alcohol, tobacco, cannabis, opioids, and sedatives. This study presents a comprehensive assessment of substance use among adults with COFP. Findings extend prior work documenting high rates of substance use among individuals with chronic pain to a sample of adults with COFP. Given that substance use can exacerbate chronic pain and interfere with pain management, findings underscore the importance of assessing and addressing substance use among individuals with COFP.
慢性口面部疼痛（COFP；即面部、口腔或下颌的肌肉骨骼、神经血管或神经性疼痛，持续至少3个月）普遍存在且使人衰弱。慢性疼痛和物质使用常常同时出现，患有COFP的个体面临着可能影响物质使用的独特挑战（例如，对未来疼痛发作的不确定性、进食、饮水和说话困难）。然而，迄今为止，尚无研究全面评估COFP患者中的物质使用情况。在此，我们调查了患有COFP的成年人中物质使用的患病率。参与者包括从面部疼痛协会招募的246名患有COFP的成年人。参与者在2023年12月至2024年1月期间完成了一项在线调查，其中包括对物质使用的全面评估（即酒精、吸烟和物质使用参与筛查测试）。大多数参与者（82.9%）一生中使用过≥1种物质，超过三分之二（68.3%）的人目前使用≥1种物质，近一半（43.5%）的人有危险物质使用行为。最常用的物质是酒精、烟草、大麻、阿片类药物和镇静剂。本研究对患有COFP的成年人中的物质使用情况进行了全面评估。研究结果将先前记录慢性疼痛患者中高物质使用率的工作扩展到了患有COFP的成年人样本。鉴于物质使用会加重慢性疼痛并干扰疼痛管理，研究结果强调了评估和解决COFP患者中物质使用问题的重要性。
